1. Anti-TNF alpha therapy and safety monitoring. Clinical tool guide elaborated by the Club Rhumatismes et Inflammation (CRI), section of the French Society of Rheumatology (Société Française de Rhumatologie, SFR);Pham;Joint Bone Spine,2005
2. Rituximab (Mabthera) therapy and safety management. Clinical tool guide elaborated by the Rheumatic Diseases and inflammation Group (Club Rhumatismes et Inflammation, CRI), of the French Society of Rheumatology (Société Française de Rhumatologie, SFR);Pham;Joint Bone Spine,2008
3. Time to treatment response with abatacept in patients with rheumatoid arhritis and an inadequate response to methotrexate;Kremer;Arthritis Rheum,2008
4. Time to treatment response with abatacept in patients with RA and an inadequate response to anti-TNF therapy;Schiff;Arthritis Rheum,2008
5. Abatacept for rheumatoid arthritis refractory to tumor necrosis factor inhibition;Genovese;N Engl J Med,2005